Cancer Research

We advance cancer research to develop new strategic fields in the fight against this disease.

What is cancer?

Cancer is one of the most important health problems in the world. In Europe, around 3 million new cases are diagnosed each year and 1.7 million people die of these diseases. The association between cancer risk and advancing age indicates that this figure will increase as the population ages.

Cancer is an umbrella term for a broad group of diseases. They are characterized by the development of abnormal cells that divide, grow and spread uncontrollably in any part of the body.

There are several types of cancer depending on their location. There may be similarities between them, but each has its own characteristics.

At Cima Universidad de Navarra, we research the origin and causes of the development of different types of cancers, with a particular interest in those that still lack effective treatments.

Our research is integrated into the Cancer Center Clínica Universidad de Navarra a reference center with a unique model of care, research, and training to provide answers to cancer patients. Thus, cancer researchers at Cima carry out their research activities in close collaboration with doctors from the Clínica Universidad de Navarra and other researchers from the University of Navarra to innovate new therapies to benefit personalized medicine for cancer patients. 

Need more information?

If you are interested in learning more about our research, please contact us.

How do we research cancer?

Cima's research is integrated into the activity of the Cancer Center Clínica Universidad de Navarra,
a reference centre for care, research and teaching in the care of cancer patients.


Icono blanco microscopio
The patient, at the center of our research


To understand the cellular and molecular mechanisms that cause cancer and its metastasis.

Identify new tumor-specific therapeutic targets.

Develop prognostic biomarkers that improve diagnosis and prediction of treatment response.

Explore new advanced genetic and cellular therapies to combat the disease.

To produce new drugs and treatments for clinical trials.